These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8552103)

  • 21. A community survey of Parkinson's disease.
    Snow B; Wiens M; Hertzman C; Calne D
    CMAJ; 1989 Sep; 141(5):418-22. PubMed ID: 2766181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Estimation of the prevalence of Parkinson's disease in Asturia, Spain. A pharmacoepidemiological study of the consumption of antiparkinson drugs].
    Martínez-Suárez MM; Blázquez-Menes B
    Rev Neurol; 2000 Dec 1-15; 31(11):1001-6. PubMed ID: 11190861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fatigue in Parkinson's disease: prevalence and associated factors.
    Beiske AG; Loge JH; Hjermstad MJ; Svensson E
    Mov Disord; 2010 Oct; 25(14):2456-60. PubMed ID: 20976741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Incidence of idiopathic and secondary Parkinson disease in Navarre. Population-based case registry].
    Viñes JJ; Larumbe R; Gaminde I; Artázcoz MT
    Neurologia; 1999 Jan; 14(1):16-22. PubMed ID: 10079687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of Parkinson's disease and other types of Parkinsonism. A door-to-door survey in Bidasoa, Spain.
    Bergareche A; De La Puente E; López de Munain A; Sarasqueta C; de Arce A; Poza JJ; Martí-Massó JF
    J Neurol; 2004 Mar; 251(3):340-5. PubMed ID: 15015016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and incidence of Parkinson's disease in Europe.
    von Campenhausen S; Bornschein B; Wick R; Bötzel K; Sampaio C; Poewe W; Oertel W; Siebert U; Berger K; Dodel R
    Eur Neuropsychopharmacol; 2005 Aug; 15(4):473-90. PubMed ID: 15963700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 50-year follow-up of the incidence of multiple sclerosis in Hordaland County, Norway.
    Grytten N; Glad SB; Aarseth JH; Nyland H; Midgard R; Myhr KM
    Neurology; 2006 Jan; 66(2):182-6. PubMed ID: 16434650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamics of parkinsonism-Parkinson's disease in residents of adjacent kibbutzim in Israel's Negev.
    Goldsmith JR; Herishanu YO; Podgaietski M; Kordysh E
    Environ Res; 1997; 73(1-2):156-61. PubMed ID: 9311541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of antiparkinsonian drugs in Denmark: results from a nationwide pharmacoepidemiological study.
    Brandt-Christensen M; Kvist K; Nilsson FM; Andersen PK; Kessing LV
    Mov Disord; 2006 Aug; 21(8):1221-5. PubMed ID: 16671076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Geographical difference in Parkinson's disease prevalence within West Scotland.
    Newman EJ; Grosset KA; Grosset DG
    Mov Disord; 2009 Feb; 24(3):401-6. PubMed ID: 19021227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parkinson's prevalence estimated by a state registry.
    Strickland D; Bertoni JM
    Mov Disord; 2004 Mar; 19(3):318-23. PubMed ID: 15022187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive predictors of dementia in Parkinson's disease: a community-based, 4-year longitudinal study.
    Janvin CC; Aarsland D; Larsen JP
    J Geriatr Psychiatry Neurol; 2005 Sep; 18(3):149-54. PubMed ID: 16100104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prevalence and clinical characteristics of pathological gambling in Parkinson's disease: an evidence-based review.
    Barns Neurauter MP; Rickards H; Cavanna AE
    Funct Neurol; 2010; 25(1):9-13. PubMed ID: 20626992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High prevalence of Parkinson's disease in the Faroe Islands.
    Wermuth L; Joensen P; Bünger N; Jeune B
    Neurology; 1997 Aug; 49(2):426-32. PubMed ID: 9270572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiological study and clinical profile of Parkinson's disease in the Assiut Governorate, Egypt: a community-based study.
    Khedr EM; Al Attar GS; Kandil MR; Kamel NF; Abo Elfetoh N; Ahmed MA
    Neuroepidemiology; 2012; 38(3):154-63. PubMed ID: 22473384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The range and nature of sleep dysfunction in untreated Parkinson's disease (PD). A comparative controlled clinical study using the Parkinson's disease sleep scale and selective polysomnography.
    Dhawan V; Dhoat S; Williams AJ; Dimarco A; Pal S; Forbes A; Tobías A; Martinez-Martin P; Chaudhuri KR
    J Neurol Sci; 2006 Oct; 248(1-2):158-62. PubMed ID: 16780888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Punding prevalence in Parkinson's disease.
    Miyasaki JM; Al Hassan K; Lang AE; Voon V
    Mov Disord; 2007 Jun; 22(8):1179-81. PubMed ID: 17230464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of Parkinson's disease in the L'Aquila district, central Italy.
    Totaro R; Marini C; Pistoia F; Sacco S; Russo T; Carolei A
    Acta Neurol Scand; 2005 Jul; 112(1):24-8. PubMed ID: 15932352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple sclerosis in Nord-Trøndelag County, Norway: a prevalence and incidence study.
    Dahl OP; Aarseth JH; Myhr KM; Nyland H; Midgard R
    Acta Neurol Scand; 2004 Jun; 109(6):378-84. PubMed ID: 15147459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Suicide attempts in Brittany (France). Distribution at the regional level].
    Batt A; Tron I; Depoivre C; Trehony A
    Encephale; 1993; 19(6):619-25. PubMed ID: 12404781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.